Ganglioglioma associated with alterations of NBN gene. A case report

Folia Neuropathol. 2009;47(3):278-83.

Abstract

We report a case of a 13-year-old girl with a tumour of the right fronto-parietal region of the brain. The tumour consisted of two components: a well-differentiated astroglial component with Rosenthal fibres and a neoplastic neuronal component. The final histopathology established diagnosis of ganglioglioma WHO grade I. The patient was selected from a group of children with central nervous system (CNS) tumours screened for the most common molecular variants in the NBN gene (exons 5 and 6). Molecular analysis revealed the presence of c.511A>G (p.Ile171Val) substitution on one allele. This is the first patient with ganglioglioma and confirmed mutation in the NBN gene.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Antineoplastic Agents / therapeutic use
  • Brain Neoplasms / genetics*
  • Brain Neoplasms / pathology
  • Brain Neoplasms / therapy
  • Cell Cycle Proteins / genetics*
  • Combined Modality Therapy
  • DNA Mutational Analysis
  • Female
  • Ganglioglioma / genetics*
  • Ganglioglioma / pathology
  • Ganglioglioma / therapy
  • Humans
  • Immunohistochemistry
  • Neurosurgical Procedures
  • Nuclear Proteins / genetics*
  • Point Mutation
  • Polymorphism, Single-Stranded Conformational
  • Radiotherapy

Substances

  • Antineoplastic Agents
  • Cell Cycle Proteins
  • NBN protein, human
  • Nuclear Proteins